The Ceftazidime for Injection, cataloged under National Stock Number 6505-01-231-4808, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc. Government technical data includes 8 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-231-4808 |
| Primary Part Number | NDC25021-0129-99 |
| Item Name | Ceftazidime for Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Content Quantity | 6.000 GRAMS OF ACTIVE INGREDIENT G |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | STERILE |
| Primary Container Type | VIAL, MULTIPLE DOSE |
| Physical Form | POWDER |
| Active Medicament Medicinal Strength | 6.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G |
| Total Primary Container Quantity | 6 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC25021-0129-99 PRIMARY | Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc (USA) |
| NDC44567-0237-06 PRIMARY | Wg Critical Care, Llc (USA) |
| Reference | Meaning |
|---|---|
| NDC00781-3179-86 | 5/9 Secondary reference Sandoz Inc. |
NSN 6505-01-231-4808 is a Ceftazidime for Injection, manufactured by Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-231-4808 has 2 manufacturer part numbers on file: NDC25021-0129-99 (Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc), NDC44567-0237-06 (Wg Critical Care, Llc).
Key specifications for NDC25021-0129-99: Administration: INTRAVENOUS; Primary Container Content Quantity: 6.000 GRAMS OF ACTIVE INGREDIENT G; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Features Provided: STERILE. 8 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.